Polyrizon已成功构建Nasarix™研究的临床中心网络,并正稳步推进至患者入组阶段。这一里程碑式的进展,标志着该公司在鼻腔给药技术领域的研究又向前迈出了关键一步。随着临床站点网络的全面落成,Polyrizon现已具备启动患者招募工作的充分条件,为后续试验的顺利开展奠定了坚实基础。
Polyrizon已成功构建Nasarix™研究的临床中心网络,并正稳步推进至患者入组阶段。这一里程碑式的进展,标志着该公司在鼻腔给药技术领域的研究又向前迈出了关键一步。随着临床站点网络的全面落成,Polyrizon现已具备启动患者招募工作的充分条件,为后续试验的顺利开展奠定了坚实基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.